In this episode of The Moss Report Podcast, Dr. Michael Gonzalez of the University of Puerto Rico shares his enthusiasm for the intersections of cancer and Quantum physics. In his conversation with Dr. Moss, they discuss a holistic approach to cancer treatment including consideration of Vitamin C, energy levels, and metabolism.

Dr. Michael J. Gonzalez, BS, MS, MHSN, DSc, NMD, PhD, FANMA, FACN is a Professor at the Nutrition Program, School of Public Health in the Medical Sciences Campus, University of Puerto Rico and Adjunct faculty at the Universidad Central del Caribe School of Medicine. Dr. Gonzalez is a Fellow of the American College of Nutrition and has authored over 250 scientific publications. He has obtained several research awards for his work on Nutrition, Supplementation, and Cancer.

Doctor Gonzalez is a founder of InBioMed, leaders in the development of non-toxic chemotherapy treatments for cancer. The findings of their work with Intravenous Vitamin C as an anti-cancer agent, published in 2002, were confirmed by the NIH in 2005. They published the first Phase-I clinical study utilizing Intravenous Vitamin C for the treatment of terminal cancer patients in 2005, and also published in 2005, the most comprehensive review on Vitamin C and Cancer, as a follow-up on the work of two times Nobel Laureate, Dr. Linus C. Pauling. He has brought many new concepts into the scientific field, such as the Bio-energetic theory of carcinogenesis, the physiological modulation concept, the systemic saturation phenomenon of intravenous vitamin C, the metabolic and mitochondrial correction model for disease treatment and prevention. Dr. Gonzalez was inducted into the International Hall of fame of Orthomolecular Medicine in April 2016. He is one of the first Latino and Puerto Rican to be inducted into the International Hall of fame of Orthomolecular Medicine.

Dr. Gonzalez is studying quantum physics to better understand energy and information, this includes laser therapy, exosomes, mitochondrial enhancement, and stem cells as therapeutic tools for degenerative diseases